ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,735Gold OADomestic Journal

Chinese Journal of Cancer Research

Acronym:cjcr
•
Abbreviation (ISO):CHINESE J CANCER RES
•
Identifier (ISSN):1000-9604(Print)/1993-0631(Online)
•
Publisher:Springer Berlin Heidelberg
Clarivate IF (2026)
6.7↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Chinese Journal of Cancer Research

WoS Q1
14693.6920182.5220194.1320205.0920214.0320225.12023720246.320256.72026
Annual Impact Factor Metric
Current (2026):6.7
Scopus SJR & RankScopus Q1
1.406
#2,735

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
51

51 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate14.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
62articles/year
100% Gold OA•84.09% Original Research

Aims & Scope

Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631; www.thecjcr.org) is published by AME Publishing Company (www.amepc.org) in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013. CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.

Topics Covered (Recognized by AI)
MedicineBiologyGeneticsInternal MedicinePathologyOncology & Cancer ResearchChemistryBiochemistryImmunologySurgeryCancer ResearchOncologyRadiologyMathematicsMolecular BiologyPhysics
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank58/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank76/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.7
Articles / Year35
Total Citations5
2025
IF6.3
Articles / Year80
Total Citations424
2024
IF7
Articles / Year56
Total Citations515
2023
IF5.1
Articles / Year56
Total Citations923
2022
IF4.026
Articles / Year60
Total Citations1,125

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,735Scopus Q1SCImago Profile
Scopus Coverage:1988-1996, 1998-2017, 2020-2025
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.406

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.92

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,545 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations920
3-Year Documents169
Citable Documents155

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ1
Cancer ResearchQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 14.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Chinese Journal of Cancer Research (acronym: cjcr, abbr: CHINESE J CANCER RES, ISSN: 1000-9604) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Berlin Heidelberg in China since 1988. The periodical holds a Journal Impact Factor (JIF) of 6.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.406 (Q1), an H-index of 51.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 62 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,545 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Springer Berlin Heidelberg
Publication Language
English
Frequency
Quarterly
Founding Year
1988
Indexing & Databases
SCIEPubMed
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 121c847d-b75c-40ea-b645-63e1e30e1698
Database Updated: 2026-09-28